You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic cholangiocarcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic Trial (Ivosidenib)

Not yet recruiting
  • Cholangiocarcinoma Non-resectable
  • Cholangiocarcinoma Metastatic
  • (no location specified)
Oct 10, 2023

Cholangiocarcinoma Trial (Carrilizumab, Albumin-bound paclitaxel, Apatinib)

Not yet recruiting
  • Cholangiocarcinoma
  • (no location specified)
Dec 9, 2022

Cholangiocarcinoma Trial (Carrelizumab, Solfantinib)

Not yet recruiting
  • Cholangiocarcinoma
  • (no location specified)
Jan 16, 2023

Cholangiocarcinoma Trial in Düsseldorf (Ivosidenib Oral Tablet)

Recruiting
  • Cholangiocarcinoma
  • Ivosidenib Oral Tablet
  • Düsseldorf, Germany
    Klinik für Gastroenterologie, Hepatologie und Infektiologie Univ
May 17, 2023

IDH1-mutant Cholangiocarcinoma Trial (Ivosidenib, Recommended Combination Dose (RCD) of ivosidenib, Nivolumab)

Not yet recruiting
  • IDH1-mutant Cholangiocarcinoma
  • (no location specified)
Jun 29, 2023

Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma, Determine Efficacy of Liver Transplantation After Neoadjuvant

Not yet recruiting
  • Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
  • Determine Efficacy of Liver Transplantation After Neoadjuvant Systemic Therapy in Patients With Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
  • Liver Transplant
  • Newark, New Jersey
  • +1 more
Nov 14, 2023

Cholangiocarcinoma, Liver Tumors Trial in Saint Louis (Floxuridine, Dexamethasone, Gemcitabine)

Terminated
  • Cholangiocarcinoma
  • Liver Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 8, 2022

Intrahepatic Cholangiocarcinoma Trial (derazantinib)

Available
  • Intrahepatic Cholangiocarcinoma
  • (no location specified)
Jan 13, 2023

Carcinoma, Intrahepatic Cholangiocarcinoma, Digestive System Tumors Trial in Guangzhou (Pemigatinib, PD-1 Inhibitors)

Recruiting
  • Carcinoma
  • +4 more
  • Guangzhou, Guangdong, China
    Lei Zhang
Jun 21, 2023

Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma, Unresectable Cholangiocarcinoma Trial in United States (Cisplatin,

Recruiting
  • Advanced Cholangiocarcinoma
  • +2 more
  • Scottsdale, Arizona
  • +7 more
Jun 24, 2022

Cholangiocarcinoma,Adult Trial (3D185)

Not yet recruiting
  • Cholangiocarcinoma,Adult
  • (no location specified)
Sep 2, 2021

Cholangiocarcinoma Trial in Shanghai (Pemigatinib)

Active, not recruiting
  • Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Oct 3, 2022

Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer

Recruiting
  • Metastatic Colorectal Cancer (Mcrc)
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)

Not yet recruiting
  • Bile Duct Cancer
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 23, 2023

Cholangiocarcinoma Metastatic Trial in China (TT-00420 (tinengotinib))

Not yet recruiting
  • Cholangiocarcinoma Metastatic
  • TT-00420 (tinengotinib)
  • Guangzhou, Guangdong, China
  • +6 more
Sep 26, 2023

Hepatocellular Carcinoma, Liver Metastases, Cholangiocarcinoma Trial in United States (STP705)

Active, not recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

Recruiting
  • Gastric Cancer
  • +6 more
  • CEA CAR-T cells
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Aug 23, 2023

Cholangiocarcinoma Non-resectable Trial in Chengdu (Candonilimab, Cisplatin, Gemcitabine)

Recruiting
  • Cholangiocarcinoma Non-resectable
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Aug 4, 2023

HRD, Cholangiocarcinoma, Metastatic Cancer Trial (Niraparib, Dostarlimab)

Withdrawn
  • HRD
  • +2 more
  • (no location specified)
Jun 23, 2022

HER2 Gene Mutation Trial in Shanghai (Injection of IAH0968+Gemcitabine+Cisplatin, Gemcitabine+Cisplatin)

Recruiting
  • HER2 Gene Mutation
  • Injection of IAH0968+Gemcitabine+Cisplatin
  • Gemcitabine+Cisplatin
  • Shanghai, China
    Fudan University Affiliated Zhongshan Hospital
Aug 7, 2023

Perihilar Cholangiocarcinoma Trial in Guangzhou (PD-1antibody plus GEMOX)

Not yet recruiting
  • Perihilar Cholangiocarcinoma
  • PD-1antibody plus GEMOX
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 31, 2022

Locally Advanced Intrahepatic Cholangiocarcinoma, Metastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

Recruiting
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • +5 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Treat Primary and Metastatic Liver Tumors

Enrolling by invitation
  • Intrahepatic Cholangiocarcinoma
  • +3 more
    • Dallas, Texas
      Methodist Dallas Medical Center
    Feb 3, 2022

    Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer Trial in Milan (Embolization)

    Recruiting
    • Hepatocellular Carcinoma
    • +6 more
    • Embolization
    • Milan, Italy
      IRCCS Ospedale San Raffaele
    Feb 3, 2023